MS-DRG 837 — Chemotherapy with Acute Leukemia as Secondary Diagnosis or with High Dose Chemotherapy Agent with MCC
MDC 17 · Myeloproliferative Diseases & Neoplasms · Medical DRG · FY2026
| FY2026 relative weight | 4.8043 |
|---|---|
| Geometric mean LOS | 10.2 days |
| Arithmetic mean LOS | 14.9 days |
| Severity tier | with MCC |
| Post-acute transfer policy | No |
| Special payment provision | No |
Figures come from the official FY2026 IPPS tables and are payment inputs, not adjudicated amounts. DRG Calculator prices full claims — hospital-specific operating, capital, IME, DSH, uncompensated care and outlier math — and verifies results against the official pricer.